-
Mashup Score: 4Pharma still 'falling short' in providing access to low- and middle-income countries, analysis finds - 2 day(s) ago
More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall industry efforts remain limited.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Why the crowded market for ambient AI medical scribes might be ripe for consolidation - 2 day(s) ago
Even as more health systems adopt ambient scribes, the technology providers might find it harder to differentiate themselves, analysts say.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Here's why one CEO compares the crowded AI medical scribe space to the market for electric scooters. https://t.co/GK4cGbe25j
-
-
Mashup Score: 3
The health care industry is depending on Republicans who loathe the ACA to extend ACA subsidies.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
The health care industry is depending on Republicans who loathe the ACA to extend ACA subsidies. https://t.co/k9lOETF0P3
-
-
Mashup Score: 7Trump picks Dr. Oz to lead Medicare and Medicaid - 2 day(s) ago
WASHINGTON — President-elect Trump has selected the surgeon and television personality Mehmet Oz as the administrator of the Center for Medicare and
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
#Breaking - Trump picks Dr. Oz to lead Medicare and Medicaid https://t.co/AER6DrnGjs
-
-
Mashup Score: 3
Through the lens of financial markets, analytics, AI, and key therapeutic areas to watch in 2025, we’ll discuss how biotech organizations can succeed next year and beyond.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Don't miss our next #STATOpenDoors community event this Thursday, November 21! We're breaking down the business of biotech in 2025 through the lens of financial markets, analytics and AI, and key therapeutic areas to watch. Register: https://t.co/R0XvEgdiSF https://t.co/k47eDjvDPD
-
-
Mashup Score: 2
While RFK Jr. has been a vocal critic of pharma, industry executives are shrugging off potential impact
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
While RFK Jr. has been a vocal critic of pharma, industry executives are shrugging off potential impact https://t.co/e0KsBPScNl
-
-
Mashup Score: 2A guide to the health systems and companies driving adoption - 2 day(s) ago
STAT has launched a Generative AI Tracker to keep tabs on the new ways health care systems are using the technology.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Stay on top of all the health care leaders and tech companies investing in generative AI with STAT's tracker. https://t.co/bfXsVUN1IM
-
-
Mashup Score: 3Why the crowded market for ambient AI medical scribes might be ripe for consolidation - 2 day(s) ago
Even as more health systems adopt ambient scribes, the technology providers might find it harder to differentiate themselves, analysts say.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet-
The number of health systems looking to contract with an AI scribe company is growing. But analysts see signs of consolidation where only the big players will survive. https://t.co/skbSArsCpC
-
-
Mashup Score: 3Two drugs look promising for lipoprotein(a), a common genetic risk factor for heart disease - 2 day(s) ago
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a “major new path” of cardiovascular therapy.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Two drugs look promising for a common genetic risk factor for heart disease https://t.co/RdRIDqEzUx
-
-
Mashup Score: 1Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast - 2 day(s) ago
.@nes047 and @NathanielEDavid formed Jupiter Bioventures to quickly test out, and if necessary discard, ideas in biotech.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast https://t.co/pBcEZoXGgc
-
More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall industry efforts remain limited. https://t.co/LNBC1kpYD1